EP4623096A4 - Fragmentomics-based identification of tumor-specific copy number changes in liquid biopsy - Google Patents

Fragmentomics-based identification of tumor-specific copy number changes in liquid biopsy

Info

Publication number
EP4623096A4
EP4623096A4 EP23895315.2A EP23895315A EP4623096A4 EP 4623096 A4 EP4623096 A4 EP 4623096A4 EP 23895315 A EP23895315 A EP 23895315A EP 4623096 A4 EP4623096 A4 EP 4623096A4
Authority
EP
European Patent Office
Prior art keywords
fragmentomics
tumor
copy number
number changes
based identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23895315.2A
Other languages
German (de)
French (fr)
Other versions
EP4623096A1 (en
Inventor
Alexander D Fine
Brennan Decker
Zheng Kuang
Chang Xu
Daokun Sun
Yanmei Huang
Jason D Hughes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foundation Medicine Inc
Original Assignee
Foundation Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foundation Medicine Inc filed Critical Foundation Medicine Inc
Publication of EP4623096A1 publication Critical patent/EP4623096A1/en
Publication of EP4623096A4 publication Critical patent/EP4623096A4/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10Ploidy or copy number detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Zoology (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP23895315.2A 2022-11-21 2023-11-20 Fragmentomics-based identification of tumor-specific copy number changes in liquid biopsy Pending EP4623096A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263427058P 2022-11-21 2022-11-21
PCT/US2023/080494 WO2024112643A1 (en) 2022-11-21 2023-11-20 Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy

Publications (2)

Publication Number Publication Date
EP4623096A1 EP4623096A1 (en) 2025-10-01
EP4623096A4 true EP4623096A4 (en) 2026-03-11

Family

ID=91196534

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23895315.2A Pending EP4623096A4 (en) 2022-11-21 2023-11-20 Fragmentomics-based identification of tumor-specific copy number changes in liquid biopsy

Country Status (2)

Country Link
EP (1) EP4623096A4 (en)
WO (1) WO2024112643A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018009723A1 (en) * 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019310041B2 (en) * 2018-07-23 2025-11-20 Guardant Health, Inc. Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
WO2022046947A1 (en) * 2020-08-25 2022-03-03 Guardant Health, Inc. Methods and systems for predicting an origin of a variant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018009723A1 (en) * 2016-07-06 2018-01-11 Guardant Health, Inc. Methods for fragmentome profiling of cell-free nucleic acids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CRISTIANO STEPHEN ET AL: "Genome-wide cell-free DNA fragmentation in patients with cancer", NATURE,, vol. 570, no. 7761, 29 May 2019 (2019-05-29), pages 385 - 389, XP036814426, [retrieved on 20190529], DOI: 10.1038/S41586-019-1272-6 *
See also references of WO2024112643A1 *

Also Published As

Publication number Publication date
EP4623096A1 (en) 2025-10-01
WO2024112643A1 (en) 2024-05-30

Similar Documents

Publication Publication Date Title
IL286352A (en) New small molecule inhibitors of tead transcription factors
EP3899864A4 (en) COMBINED EVALUATION OF MORPHOLOGICAL AND PERIVASCULAR PATHOLOGY MARKERS
Zhao et al. Effect of YAP1 silencing on esophageal cancer
EP4233350A4 (en) GAPS-BASED CARRIER-SPECIFIC SCALE FACTOR IMPROVEMENT
EP4402480A4 (en) Serum immune-based biomarkers for use in ALS therapy
EP3705580A4 (en) PROCEDURE FOR INTRAORAL INSPECTION USING INFORMATION FOR GROUPS OF BACTERIA ASSOCIATED WITH CLINICAL INDICES
EP4058606A4 (en) IDENTIFICATION OF HOST RNA BIOMARKERS OF INFECTIONS
EP4408439A4 (en) Rhenium nanomaterial-based inhibitors of inflammation and cancer metastases
EP4469893A4 (en) HOST GUEST NOTIFICATION
EP4436992A4 (en) BINDING DOMAIN MOLECULES ON CELL SURFACES
EP4744051A1 (en) Classification of breast tumors by means of DNA methylation from liquid biopsy
ES2436667R1 (en) SERUM BIOMARCATOR TO DIAGNOSTIC COLORRECTAL CANCER
Sattar et al. Malignant mesothelioma presenting as recurrent hydro-pneumothorax: an atypical case presentation and literature review
EP4486914A4 (en) DETOUR PROBE
KR102427539B9 (en) Two-photon fluorescent probe for detection of cyclooxygenase-2 and use thereof
EP4504734A4 (en) Fluorescence imaging probes
EP4306327C0 (en) 3D pop-up card
EP4581588A4 (en) SIGN AND PRICE ASSIGNMENT FOR NEIGHBORING USERS
EP4507797A4 (en) CARD SLEEVE
JP1773803S (en) Point of sale cash register
EP3924508A4 (en) CHROMATIN MAPPING ASSAYS AND KITS USING LONG READ SEQUENCING
JP1756638S (en) Side table for cash register for point of sale information management
Sarthou Policy instruments to promote women participation in science: the L’Oréal-unesco prizes in Argentina
JP1762523S (en) Cash register for point of sale information management
JP1762430S (en) Cash register for point of sale information management

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20250619

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C12Q0001680600

Ipc: G16B0020100000

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20260209

RIC1 Information provided on ipc code assigned before grant

Ipc: G16B 20/10 20190101AFI20260203BHEP

Ipc: G16B 40/20 20190101ALI20260203BHEP

Ipc: C12Q 1/6806 20180101ALI20260203BHEP

Ipc: C12Q 1/6869 20180101ALI20260203BHEP